Tilray’s Aphria RX Receives Cannabis Trading License in Germany, Significantly Expanding Commercial Growth Opportunities NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in medical cannabis research, cultivation, production, and...

Tilray Provides International Cannabis Update on Milestone German Cannabis Legalization Tilray is bullish on the positive paradigm shift that the new German drug policy creates for the future of cannabis in Europe.